These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22983645)

  • 1. Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility.
    Ochi M; Inoue R; Yamauchi Y; Yamada S; Onoue S
    Pharm Res; 2013 Feb; 30(2):377-86. PubMed ID: 22983645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.
    Aghazadeh-Habashi A; Jamali F
    Eur J Pharm Biopharm; 2008 Nov; 70(3):889-94. PubMed ID: 18715548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amorphous Solid Dispersion of Meloxicam Enhanced Oral Absorption in Rats With Impaired Gastric Motility.
    Suzuki H; Yakushiji K; Matsunaga S; Yamauchi Y; Seto Y; Sato H; Onoue S
    J Pharm Sci; 2018 Jan; 107(1):446-452. PubMed ID: 28551427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved absorption of meloxicam via salt formation with ethanolamines.
    Han HK; Choi HK
    Eur J Pharm Biopharm; 2007 Jan; 65(1):99-103. PubMed ID: 16919925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles.
    Bartos C; Ambrus R; Sipos P; Budai-Szűcs M; Csányi E; Gáspár R; Márki Á; Seres AB; Sztojkov-Ivanov A; Horváth T; Szabó-Révész P
    Int J Pharm; 2015 Aug; 491(1-2):198-207. PubMed ID: 26142244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle engineering/different film approaches for earlier absorption of meloxicam.
    Farid M; El-Setouhy DA; El-Nabarawi MA; El-Bayomi T
    Drug Deliv; 2016 Sep; 23(7):2309-2317. PubMed ID: 25431841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors.
    Ochi M; Kawachi T; Toita E; Hashimoto I; Yuminoki K; Onoue S; Hashimoto N
    Int J Pharm; 2014 Oct; 474(1-2):151-6. PubMed ID: 25138254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical and Pharmacokinetic Characterization of Amorphous Solid Dispersion of Meloxicam with Enhanced Dissolution Property and Storage Stability.
    Ochi M; Kimura K; Kanda A; Kawachi T; Matsuda A; Yuminoki K; Hashimoto N
    AAPS PharmSciTech; 2016 Aug; 17(4):932-9. PubMed ID: 27435198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of timing of oral meloxicam administration on physiological responses in calves after cautery dehorning with local anesthesia.
    Allen KA; Coetzee JF; Edwards-Callaway LN; Glynn H; Dockweiler J; KuKanich B; Lin H; Wang C; Fraccaro E; Jones M; Bergamasco L
    J Dairy Sci; 2013 Aug; 96(8):5194-205. PubMed ID: 23746590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and multiple-dose pharmacokinetics of meloxicam after oral administration to the rabbit (Oryctolagus cuniculus).
    Carpenter JW; Pollock CG; Koch DE; Hunter RP
    J Zoo Wildl Med; 2009 Dec; 40(4):601-6. PubMed ID: 20063804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profiles of meloxicam in turtles (Trachemys scripta scripta) after single oral, intracoelomic and intramuscular administrations.
    Di Salvo A; Giorgi M; Catanzaro A; Deli G; della Rocca G
    J Vet Pharmacol Ther; 2016 Feb; 39(1):102-5. PubMed ID: 26789011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence in dogs of a meloxicam formulation administered as a transmucosal oral mist with an orally administered pioneer suspension product.
    Lees P; Cheng Z; Keefe TJ; Weich E; Bryd J; Cedergren R; Cozzi E
    J Vet Pharmacol Ther; 2013 Feb; 36(1):78-84. PubMed ID: 22533512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and pharmacokinetics of oral meloxicam in llamas.
    Kreuder AJ; Coetzee JF; Wulf LW; Schleining JA; KuKanich B; Layman LL; Plummer PJ
    BMC Vet Res; 2012 Jun; 8():85. PubMed ID: 22720782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration.
    Agarwal V; Alayoubi A; Siddiqui A; Nazzal S
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1681-9. PubMed ID: 23072611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of meloxicam after intravenous, intramuscular, and oral administration of a single dose to Hispaniolan Amazon parrots (Amazona ventralis).
    Molter CM; Court MH; Cole GA; Gagnon DJ; Hazarika S; Paul-Murphy JR
    Am J Vet Res; 2013 Mar; 74(3):375-80. PubMed ID: 23438111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Concentration of Meloxicam in Pediatric Rats.
    Pugh KA; Reitnauer KJ; Lee RB; Wilkins WL; McDonough JH; Pennington MR; Litvin SR
    J Am Assoc Lab Anim Sci; 2017 Nov; 56(6):762-767. PubMed ID: 29256371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of meloxicam in adult goats: a comparative study of subcutaneous, oral and intravenous administration.
    Karademir U; Erdogan H; Boyacioglu M; Kum C; Sekkin S; Bilgen M
    N Z Vet J; 2016 May; 64(3):165-8. PubMed ID: 26612429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of meloxicam administered orally to rabbits (Oryctolagus cuniculus) for 29 days.
    Delk KW; Carpenter JW; KuKanich B; Nietfeld JC; Kohles M
    Am J Vet Res; 2014 Feb; 75(2):195-9. PubMed ID: 24471756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
    Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
    Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Emulsifying Drug Delivery System of Celecoxib for Avoiding Delayed Oral Absorption in Rats with Impaired Gastric Motility.
    Yakushiji K; Sato H; Ogino M; Suzuki H; Seto Y; Onoue S
    AAPS PharmSciTech; 2020 May; 21(5):135. PubMed ID: 32419073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.